Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Alerts Public To Ongoing Safety Review Of Orlistat In GSK, Roche Drugs

This article was originally published in The Tan Sheet

Executive Summary

FDA's announcement it is investigating a possible risk of liver injury related to orlistat - the active ingredient in Roche Pharmaceuticals' prescription weight-loss drug Xenical and GlaxoSmithKline's OTC alli - could threaten short-term sales
Advertisement

Related Content

Alli Recall Could Help Mitigate Reputation Damage In Face Of Tampering
Alli Recall Could Help Mitigate Reputation Damage In Face Of Tampering
Alli Recall Could Help Mitigate Reputation Damage In Face Of Tampering
Alli Recall Could Help Mitigate Reputation Damage In Face Of Tampering
GSK adds alli warning
Advisory committee to evaluate FDA's orlistat review
Glaxo Adds Alli Warning Label In Europe
GSK Upbeat On Alli In EU As Global Consumer Sales Show Healthy Gains
FDA evaluates orlistat
FDA To Complete Prilosec, Nexium Safety Review In November, CDER Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS103274

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel